The Deininger labs expertise is translational research in leukemia, specifically the biology of myeloid malignancies and the development of molecular targeted therapies. We strive to understand the molecular mechanisms allowing leukemia cells to survive treatment and use this knowledge to develop more effective and less toxic therapies. We employ a multidisciplinary approach to research, straddling genetics, biochemistry, molecular biology, pharmacology, and biomedical engineering, with one goal: improving the lives of patients affected by leukemia. We are proud of our vibrant, diverse, and inclusive team of scientists who strive to improve the prevention, diagnosis, and treatment of myeloid malignancies.